Tubular phosphate transport: a comparison between different methods of urine sample collection in FGF23-dependent hypophosphatemic syndromes
- PMID: 38295343
- DOI: 10.1515/cclm-2023-1292
Tubular phosphate transport: a comparison between different methods of urine sample collection in FGF23-dependent hypophosphatemic syndromes
Abstract
Objectives: Tubular maximum phosphate reabsorption per glomerular filtration rate (TmP/GFR) is used to evaluate renal phosphate reabsorption and it is a useful tool for the differential diagnosis of hypophosphatemic syndromes. TmP/GFR is typically calculated from fasting plasma and second morning void urine samples, obtained 2 h after the first void (TmP/GFR 2 h). The purpose of this study was to evaluate if TmP/GFR calculated from 24 h urine collection (TmP/GFR 24 h) can be used as an alternative for TmP/GFR 2 h in patients with urine phosphate wasting.
Methods: We enrolled adult patients with X-linked hypophosphatemia (XLH) or tumor-induced osteomalacia (TIO). All patients underwent blood and urine sample collections, to calculate TmP/GFR 24 h and TmP/GFR 2 h.
Results: Twenty patients (17 XLH and 3 TIO), aged 24-78 years, were included. All patients had low TmP/GFR 2 h (0.35 mmol/L, IQR 0.24-0.47 mmol/L) and TmP/GFR 24 h (0.31 mmol/L, IQR 0.22-0.43 mmol/L). The concordance correlation coefficient between TmP/GFR 2 h and TmP/GFR 24 h was 0.86 (95 % CI: 0.69-0.93), with a systematic bias of 0.05 mmol/L (95 % limits of agreement: -0.10 to 0.20). Furthermore, in 70 % (i.e., 14 patients out of 20) and 80 % (i.e., 16 patients out of 20) of cases the difference between TmP/GFR 2 h and TmP/GFR 24 h was within ±30 % and ±35 %, respectively.
Conclusions: Despite TmP/GFR 2 and 24 h show a relatively suboptimal agreement, the difference between the two parameters appears to be small and not clinically significant in the setting of adult patients with FGF23-dependent urine phosphate wasting and secondary hypophosphatemia.
Keywords: X-linked hypophosphatemia (XLH); hypophosphatemic rickets; phosphate metabolism; tubular maximum phosphate reabsorption per glomerular filtration rate (TmP/GFR); tumor-induced osteomalacia (TIO).
© 2024 the author(s), published by De Gruyter, Berlin/Boston.
References
-
- Marks, J, Debnam, ES, Unwin, RJ. Phosphate homeostasis and the renal-gastrointestinal axis. Am J Physiol Ren Physiol 2010;299:F285–96. https://doi.org/10.1152/ajprenal.00508.2009 . - DOI
-
- Penido, MGMG, Alon, US. Phosphate homeostasis and its role in bone health. Pediatr Nephrol 2012;27:2039–48. https://doi.org/10.1007/s00467-012-2175-z . - DOI
-
- Blaine, J, Chonchol, M, Levi, M. Renal control of calcium, phosphate, and magnesium homeostasis. Clin J Am Soc Nephrol 2015;10:1257–72. https://doi.org/10.2215/cjn.09750913 . - DOI
-
- Fukumoto, S. FGF23-related hypophosphatemic rickets/osteomalacia: diagnosis and new treatment. J Mol Endocrinol 2021;66:R57–65. https://doi.org/10.1530/jme-20-0089 . - DOI
-
- Carpenter, TO, Shaw, NJ, Portale, AA, Ward, LM, Abrams, SA, Pettifor, JM. Rickets. Nat Rev Dis Primers 2017;3:17101. https://doi.org/10.1038/nrdp.2017.101 . - DOI